The cellular prion protein beyond prion diseases.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
20 04 2020
Historique:
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 19 8 2021
Statut: epublish

Résumé

The cellular prion protein (PrPC), a cell surface glycoprotein originally identified for its central role in prion diseases (also called transmissible spongiform encephalopathies), has recently been implicated in the pathogenesis of other neurodegenerative disorders, such as Alzheimer’s and Parkinson’s diseases, by acting as a toxicity-transducing receptor for different misfolded protein isoforms, or in some case by exerting neuroprotective effects. Interestingly, PrPC has also been reported to play unexpected functions outside the nervous system, for example by contributing to myelin homeostasis, regulating specific processes of the immune system and participating in various aspects of cancer progression. Collectively, these observations point to a much broader role for PrPC in physiological and disease processes than originally assumed. In this manuscript, we provide an overview of what is known about the role of PrPC beyond prion disorders and discuss the potential implications of targeting this protein in different diseases.

Identifiants

pubmed: 32330284
doi: 10.4414/smw.2020.20222
pii: Swiss Med Wkly. 2020;150:w20222
doi:
pii:

Substances chimiques

Prion Proteins 0
Prions 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20222

Auteurs

Giorgia Manni (G)

Department of Experimental Medicine, University of Perugia, Italy.

Victoria Lewis (V)

Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.

Matteo Senesi (M)

Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia.

Giovanni Spagnolli (G)

Dulbecco Telethon Laboratory of Prions and Amyloids, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Italy.

Francesca Fallarino (F)

Department of Experimental Medicine, University of Perugia, Italy.

Steven J Collins (SJ)

Department of Medicine (Royal Melbourne Hospital), The University of Melbourne, Parkville, Victoria, Australia / Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.

Sophie Mouillet-Richard (S)

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, France.

Emiliano Biasini (E)

Dulbecco Telethon Laboratory of Prions and Amyloids, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH